Methodology

Overview

This economic model quantifies the annual costs of occupational health hazards associated with interventional fluoroscopy in the United States. The model follows the methodology established in the original 2018 ORSIF Economic Study, updated with current data and federal economic valuations.

The model estimates costs for two primary categories of health effects:

• Cancer: Both fatal and non-fatal cancers attributable to occupational radiation exposure
• Musculoskeletal Disorders (MSDs): Injuries from wearing heavy personal protective equipment (PPE)

Workforce Estimates

The at-risk population includes physicians and support staff who work in interventional fluoroscopy settings:

Physicians

Specialty	2018 Count	2025 Count	Source	Status
Interventional Cardiologists	3,255	5,639	AAMC 2023	Confirmed
Interventional Radiologists	3,358	3,358	2018 baseline	Placeholder
Electrophysiologists	1,925	2,629	ABIM 2025	Confirmed
Total Physicians	8,538	11,626

Support Staff

Role	2018 Count	2025 Count	Source	Status
Nurses	13,000	13,000	2018 estimate	Placeholder
Technicians	11,300	11,300	2018 cath-lab specific	Placeholder
Total Support	24,300	24,300

Note: BLS reports 64,700 "Cardiovascular Technologists and Technicians" but this broader category includes echo technicians, stress test technicians, and others not routinely exposed to fluoroscopy. The 2018 cath-lab-specific estimates are used pending updated data from the IMV Cath Lab Survey.

Cancer Risk Model

Cancer risk is based on the Linear No-Threshold (LNT) model established by the National Academies' BEIR VII report (2006), which found that the risk of cancer from ionizing radiation increases linearly with dose.

Key Assumptions

• Lifetime mean occupational exposure: 100 mSv (physicians), 50 mSv (support staff)
• Lifetime cancer risk at 100 mSv: 1% (1 in 100)
• 50% of occupational cancers are fatal
• Career duration: 25 years

Current Dose Context: The 5-Year Occupational Radiation Exposure Study (2018-2022) found that cardiologists had an average mean effective dose (AMED) of 3.469 mSv in 2022. Over a 25-year career at this rate, cumulative exposure would reach approximately 87 mSv—consistent with our 100 mSv lifetime assumption. Current NRC occupational limits permit up to 50 mSv/year whole body dose, and ICRP recommends 20 mSv/year averaged over 5 years.

Cancer Cost Valuation

Fatal cancer costs are valued using the Value of Statistical Life (VSL), a standard economic metric used by federal agencies to assess the benefits of life-saving regulations.

• VSL (2025): $13.6 million (HHS February 2025 guidelines)
• VSL Range: $6.3 million to $20.7 million
• Non-fatal cancer: $250,000 per case (treatment + lost productivity)

Musculoskeletal Disorder (MSD) Model

MSDs result from wearing heavy lead aprons and other personal protective equipment, combined with prolonged standing and awkward positioning during procedures.

Prevalence Data

• 2018 SCAI Survey: 53% of interventional cardiologists reported treatment for neck/back pain
• 2023 SCAI Survey: 66% reported musculoskeletal problems
• Cervical injury rate: 10x higher than general population
• Lumbar injury rate: 3x higher than general population

Incidence Calculation

MSD Cost Valuation

MSD costs are based on workers' compensation data from the National Safety Council:

• Spine injury (physicians): $94,285 (NSC 2023)
• Average MSD (support staff): $47,316 (NSC 2023)

Physician costs are higher due to: (1) salary-based wage indemnity, and (2) higher incidence of severe cervical/lumbar injuries.

Limitations

The economic model does not attempt to quantify several consequences that could arise from adverse health effects of chronic exposure to ionizing radiation:

• Cataracts: While interventional physicians show significantly higher rates of lens opacities (14-17% vs 5-6% in controls per IC-CATARACT and O'CLOC studies), progression rates to visually significant cataracts requiring surgery remain unknown. The ICRP recognized this risk by lowering the recommended annual eye lens limit from 150 mSv to 20 mSv in 2012—a sevenfold reduction—but economic impact is not quantified here.
• Cognitive Decline: Studies show premature brain aging in interventionalists, but economic impact is difficult to quantify.
• Reproductive Health: Limited data on fertility impacts and pregnancy complications.
• Physician Replacement Costs: Early retirement due to MSDs or cancer may cost hospitals $1.8-2.8 million per physician to replace.
• Lost Procedure Revenue: Work absences and reduced caseloads impact hospital revenue (not quantified).
• Litigation: Potential future lawsuits from affected healthcare workers (not quantified).

Data Sources

Radiation Risk & Cancer

• BEIR VII Report (2006)
  National Academies: Health Risks from Exposure to Low Levels of Ionizing Radiation. Basis for Linear No-Threshold (LNT) model used in cancer risk calculations.
  nap.nationalacademies.org/catalog/11340
• 5-Year Occupational Radiation Exposure Study (2025)
  Analysis of occupational radiation trends 2018-2022. Cardiologists AMED 3.469 mSv (2022).
  Radioprotection Journal
• Brain Tumor Registry (Roguin et al.)
  43 documented brain tumors among interventional cardiologists; 85% left-sided.
  EuroIntervention
• Mayo Clinic Occupational Health Study (Orme et al. 2015)
  Higher rates of breast cancer and leukemia among interventional HCPs vs controls.
  J Am Coll Cardiol. 2015;65:820-6
• HARMONIC Study (EU - Ongoing)
  European study on cumulative radiation dose and cancer risk in medical workers.
  PMC Full Text

Economic Valuation

• HHS Standard RIA Values (February 2025)
  Office of the Assistant Secretary for Planning and Evaluation. VSL: $13.6 million (range $6.3M-$20.7M).
  aspe.hhs.gov/reports/standard-ria-values
• DOT VSL Guidance (2024)
  Department of Transportation revised VSL guidance: $13.2-13.7 million.
  transportation.gov
• EPA Mortality Risk Valuation
  EPA VSL methodology and current values for regulatory analysis.
  epa.gov/environmental-economics
• NSC Injury Facts - Workers' Compensation Costs (2023)
  National Safety Council: Average workers' comp claim $47,316; spine injuries $94,285.
  injuryfacts.nsc.org
• Physician Replacement Cost Analysis
  AMN Healthcare: Replacement cost $1.8-2.8M; IC generates $3.48M/year revenue.
  AMN Healthcare

Workforce Data

• AAMC Physician Specialty Data Report (2023)
  Association of American Medical Colleges: Interventional cardiologists grew to 5,639.
  aamc.org/data-reports/workforce
• ABIM Board Certification Statistics (2025)
  American Board of Internal Medicine: 10,815 IC certified (6,305 active); 4,034 EP certified (2,629 active).
  ABIM Blog - Spring 2025 Summary
• BLS Cardiovascular Technologists (2024)
  Bureau of Labor Statistics: 64,700 jobs; median wage $67,260. Note: broader category than cath lab specific.
  bls.gov/ooh/healthcare

Musculoskeletal Disorders

• SCAI 2023 Membership Survey
  66% MSD prevalence; 60% orthopedic injuries; 3x lumbar, 10x cervical vs general population.
  JSCAI Open Access | PMC Full Text
• SCAI 2014 Survey (Klein et al.)
  53% reported treatment for neck/back pain; basis for 2018 study MSD estimates.
  Catheter Cardiovasc Interv. 2015;86:913-24
• German MSD Study (2025)
  BMC Musculoskeletal Disorders: Lumbar complaints 82%, cervical 78% among interventionalists.
  BMC Open Access
• Mayo Clinic MSD Study (Orme et al. 2015)
  Interventional HCPs had significantly higher MSD pain than controls; techs/nurses > physicians.
  J Am Coll Cardiol. 2015;65:820-6
• Occupational Health Hazards in the Interventional Laboratory (Klein et al. 2009)
  Foundational paper on PPE strain and musculoskeletal injury mechanisms.
  J Vasc Interv Radiol. 2009;20:147-153

Cataracts & Eye Lens

• ICRP Publication 118 (2012)
  International Commission on Radiological Protection: 20 mSv/year eye lens limit (reduced from 150 mSv).
  icrp.org
• IAEA Cataract Staff Protection Guidance
  International Atomic Energy Agency: Implications for occupational radiation protection.
  iaea.org/resources/rpop
• IC-CATARACT Study (Karatasakis et al. 2018)
  14% frank opacities in interventionalists vs 6% controls.
  Catheter Cardiovasc Interv. 2018;91:647-654
• O'CLOC Study (France)
  PSC lens opacities 17% in interventional cardiologists vs 5% in controls.
  PubMed

Cognitive & Vascular Effects

• Healthy Cath Lab - Neuropsychological Testing (Marazziti et al. 2015)
  Interventionalists showed lower verbal memory and fluency scores; "premature brain aging."
  J Int Neuropsychol Soc. 2015;21:670-9
• Healthy Cath Lab - Vascular Aging (Andreassi et al. 2015)
  Increased carotid intima-media thickness and shorter telomere length in interventionalists.
  JACC Cardiovasc Interv. 2015;8:616-27

Procedure Trends

• Radial vs Femoral Access Trends (SCAI 2024)
  Radial access increased from 20.3% to 68.2% (2013-2022).
  scai.org

Regulatory & Guidance

• OSHA Ionizing Radiation Standards
  Occupational Safety and Health Administration exposure limits and guidelines.
  osha.gov/ionizing-radiation
• NRC Occupational Dose Limits
  Nuclear Regulatory Commission: 10 CFR Part 20.1201 annual dose limits.
  nrc.gov

Foundational Studies

• Original ORSIF Economic Study (December 2018)
  Economic Impacts of Radiation Exposures Associated with Interventional Fluoroscopy. Baseline $49 million estimate.
  orsif.org
• Prevalence of Spinal Disc Disease (Ross et al. 1997)
  First study documenting higher rates of spinal disc disease among interventional cardiologists.
  Am J Cardiol. 1997;79:68-70
• Orthopedic Afflictions Editorial (Goldstein 2015)
  "Tales from the working wounded" - concern about shortened careers.
  J Am Coll Cardiol. 2015;65:827-29